| Similar Articles |
|---|
 |
Chemistry World
June 2011 |
Column: In the pipeline Chemists are human. Humans are hierarchical. Therefore...well, therefore, you'll find a number of different roles and levels for scientists in a drug company's labs. Here's a rough ordering, from least experienced to most.   |
Chemistry World
October 2, 2013
Rebecca Trager |
US employment picture brightens for chemists The employment picture for US chemists and chemical engineers brightened from 2012 to 2013, with the jobless rate dropping from 4.2% to 3.5% and median salaries for all chemists increasing by 2.2%. |
Chemistry World
November 27, 2013
Derek Lowe |
Rolling boulders uphill A lot of preclinical projects don't even get off the ground, and many that do still never deliver anything to the development groups. |
Chemistry World
August 2007
Derek Lowe |
Opinion: In the Pipeline Process chemists just don't get the credit they deserve. |
Pharmaceutical Executive
October 1, 2005
Brad Miles |
Value Today for Drugs Tomorrow The industry can help its bad rep by communicating the promise of its pipeline -- and the value of its companies. |
Chemistry World
March 6, 2013
Jon Evans |
Data challenges for UK chemists Academic chemists in the UK have a problem with data. That's the claim made by a report that says that both in terms of managing and sharing data produced by their own laboratories and accessing data produced by others, chemists are all at sea. |
HHMI Bulletin
Nov 2011
Sarah C.P. Williams. |
Carolyn Bertozzi: Changed Expectations Chemists trained in biology were once a rarity -- now they're becoming the norm. |
Pharmaceutical Executive
December 1, 2013
Peter Young |
2013 Pharma and Biotech Financial Report Big Pharma and biotech continue to need each other. But biotech is feeling slightly more confident as the options for IPOs get better. |
Job Journal
July 16, 2006
Julia Hollister |
Biotech Boom The biotech field offers promising jobs in a profession that's expanding faster than you can spell biotherapeutics. |
Chemistry World
November 30, 2012
Andy Extance |
Chemists cull compounds using 'intuition' Medicinal chemists might be using far fewer parameters to choose candidate fragments for a screening collection than they think they do. Their choices can be mimicked based on just one or two properties, a team led by researchers at Swiss-headquarted pharmaceutical firm Novartis has found. |
Chemistry World
June 2008 |
Column: In the pipeline The author, a medicinal chemist working on preclinical drug discovery, takes a look at the differences between chemists and biologists working on the same team. |
Chemistry World
July 6, 2007
Richard Van Noorden |
Whitesides Charges to the Top US chemist George Whitesides has overtaken Harvard compatriot E. J. Corey to top a league table measuring the research achievements of living chemists. |
Chemistry World
June 2010 |
Column: In the pipeline Derek Lowe looks into his crystal ball to see what the future of medicinal chemistry might be |
Chemistry World
December 2008
Richard Van Noorden |
Editorial: Fiction failure Rare as it is for chemistry and its ideas to star in fiction, it's rarer still to find a story with a character who happens to be a chemist, but is also simply a well-rounded human being. |
Chemistry World
May 2006
Lee Higham |
Comment: A Case of Job Dissatisfaction A chemistry degree ought to prepare its graduates for a range of disciplines, such as finance or industry. Some students who choose the subject don't wish to work in those environments though; they are motivated by an academic path. |
Chemistry World
February 2009
Richard Van Noorden |
Editorial: Survival of the fattest The results of the UK's 2008 research assessment exercise, a national audit of university research quality, were announced late last year, and they were good news for the country's chemistry departments. |
Chemistry World
March 2012 |
Column: In the pipeline Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love |
Chemistry World
May 25, 2007
Richard Van Noorden |
Keeping it Green Some chemistry enthusiastically labeled as green may be nothing of the kind, warn researchers who worry that mediocre -- if well-meaning -- science is damaging their subject. |
Chemistry World
August 2010 |
Column: In the pipeline Derek Lowe reminisces about lost laboratory techniques and wonders which will be next to go |
The Motley Fool
December 20, 2007
Brian Orelli |
2007: The Year Pharma Fell in Love With Biologics The reason for pharma's newfound infatuation for biotech is quite clear. Many pharmaceutical companies are facing a patent cliff in the coming years, and they need to replace their blockbusters with something. |
Chemistry World
December 8, 2011
Sarah Houlton |
Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry. |
Chemistry World
January 2012 |
A new year and a new dawn As the International Year of Chemistry drew to a close last year, we were delighted to see the future of chemistry in the UK being bolstered with two universities planning to reopen their chemistry departments |
